NM_003664.5:c.1040+9T>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_003664.5(AP3B1):c.1040+9T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000431 in 1,585,718 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 1 hom. )
Consequence
AP3B1
NM_003664.5 intron
NM_003664.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0800
Publications
0 publications found
Genes affected
AP3B1 (HGNC:566): (adaptor related protein complex 3 subunit beta 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is part of the heterotetrameric AP-3 protein complex which interacts with the scaffolding protein clathrin. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2012]
AP3B1 Gene-Disease associations (from GenCC):
- Hermansky-Pudlak syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 5-78177330-A-T is Benign according to our data. Variant chr5-78177330-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 464882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00215 (328/152322) while in subpopulation AFR AF = 0.00729 (303/41572). AF 95% confidence interval is 0.00661. There are 0 homozygotes in GnomAd4. There are 169 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP3B1 | NM_003664.5 | c.1040+9T>A | intron_variant | Intron 9 of 26 | ENST00000255194.11 | NP_003655.3 | ||
AP3B1 | NM_001271769.2 | c.893+9T>A | intron_variant | Intron 9 of 26 | NP_001258698.1 | |||
AP3B1 | NM_001410752.1 | c.1040+9T>A | intron_variant | Intron 9 of 22 | NP_001397681.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00215 AC: 327AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
327
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000598 AC: 150AN: 250688 AF XY: 0.000443 show subpopulations
GnomAD2 exomes
AF:
AC:
150
AN:
250688
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000248 AC: 356AN: 1433396Hom.: 1 Cov.: 25 AF XY: 0.000231 AC XY: 165AN XY: 714946 show subpopulations
GnomAD4 exome
AF:
AC:
356
AN:
1433396
Hom.:
Cov.:
25
AF XY:
AC XY:
165
AN XY:
714946
show subpopulations
African (AFR)
AF:
AC:
280
AN:
32906
American (AMR)
AF:
AC:
29
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25930
East Asian (EAS)
AF:
AC:
0
AN:
39528
South Asian (SAS)
AF:
AC:
6
AN:
85308
European-Finnish (FIN)
AF:
AC:
0
AN:
53348
Middle Eastern (MID)
AF:
AC:
1
AN:
5716
European-Non Finnish (NFE)
AF:
AC:
3
AN:
1086728
Other (OTH)
AF:
AC:
37
AN:
59390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00215 AC: 328AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.00227 AC XY: 169AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
328
AN:
152322
Hom.:
Cov.:
32
AF XY:
AC XY:
169
AN XY:
74484
show subpopulations
African (AFR)
AF:
AC:
303
AN:
41572
American (AMR)
AF:
AC:
19
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5196
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68028
Other (OTH)
AF:
AC:
4
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jan 14, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Hermansky-Pudlak syndrome 2 Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autoinflammatory syndrome Benign:1
Sep 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.